Drugs / FPT-20
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05399212 | Oct 2020 → May 2026 | spermatogenic failure | Trieu, Nguyen Thi, M.D. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FPT-20 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05399212 ↗ |
| Route | Oral | “Participants receive FPT-20 orally at a standardized dosage of 1 tablet once daily.” NCT05399212 ↗ |